Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug interactions with tacrolimus.
van Gelder T. van Gelder T. Drug Saf. 2002;25(10):707-12. doi: 10.2165/00002018-200225100-00003. Drug Saf. 2002. PMID: 12167066 Review.
Renal function as a predictor of irinotecan-induced neutropenia.
de Jong FA, van der Bol JM, Mathijssen RH, van Gelder T, Wiemer EA, Sparreboom A, Verweij J. de Jong FA, et al. Among authors: van der bol jm, van gelder t. Clin Pharmacol Ther. 2008 Aug;84(2):254-62. doi: 10.1038/sj.clpt.6100513. Epub 2008 Feb 20. Clin Pharmacol Ther. 2008. PMID: 18288083
Effects of CYP induction by rifampicin on tamoxifen exposure.
Binkhorst L, van Gelder T, Loos WJ, de Jongh FE, Hamberg P, Moghaddam-Helmantel IM, de Jonge E, Jager A, Seynaeve C, van Schaik RH, Verweij J, Mathijssen RH. Binkhorst L, et al. Among authors: van gelder t, van schaik rh. Clin Pharmacol Ther. 2012 Jul;92(1):62-7. doi: 10.1038/clpt.2011.372. Epub 2012 May 23. Clin Pharmacol Ther. 2012. PMID: 22617226 Clinical Trial.
Individualization of tamoxifen treatment for breast carcinoma.
Binkhorst L, van Gelder T, Mathijssen RH. Binkhorst L, et al. Among authors: van gelder t. Clin Pharmacol Ther. 2012 Oct;92(4):431-3. doi: 10.1038/clpt.2012.94. Epub 2012 Aug 22. Clin Pharmacol Ther. 2012. PMID: 22910442 Review.
Doubt about the feasibility of preemptive genotyping.
Koch BC, van Schaik RH, van Gelder T, Mathijssen RH; Rotterdam Clinical Pharmacology-Pharmacogenetics Group (RCPPG). Koch BC, et al. Among authors: van gelder t, van schaik rh. Clin Pharmacol Ther. 2013 Mar;93(3):233. doi: 10.1038/clpt.2012.191. Epub 2012 Dec 12. Clin Pharmacol Ther. 2013. PMID: 23232547 No abstract available.
473 results